What is the weight-based dose of Cepodoxime (Cefpodoxime) for pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefpodoxime Weight-Based Dosing in Pediatric Patients

For pediatric patients aged 2 months through 12 years, cefpodoxime is dosed at 10 mg/kg/day (maximum 400 mg/day) divided into two doses given every 12 hours, with 5 mg/kg per dose (maximum 200 mg/dose). 1

Standard Dosing by Indication

Acute Otitis Media

  • 10 mg/kg/day divided every 12 hours for 5 days 1
  • Maximum daily dose: 400 mg/day 1
  • Maximum single dose: 200 mg 1

Pharyngitis and Tonsillitis

  • 10 mg/kg/day divided every 12 hours for 5 to 10 days 1
  • Maximum daily dose: 200 mg/day 1
  • Maximum single dose: 100 mg 1
  • Note the lower maximum dose compared to otitis media 1

Acute Maxillary Sinusitis

  • 10 mg/kg/day divided every 12 hours for 10 days 1
  • Maximum daily dose: 400 mg/day 1
  • Maximum single dose: 200 mg 1

Clinical Context and Alternative Therapy

Cefpodoxime serves as an alternative oral agent for community-acquired pneumonia when treating Streptococcus pneumoniae with penicillin MICs <2.0 μg/mL, using the same 8-10 mg/kg/day dosing divided twice daily 2. It is also recommended as an alternative for Haemophilus influenzae infections, particularly when β-lactamase production is present 3, 2.

Administration Considerations

Food Effects

  • Cefpodoxime can be administered without regard to meals in children 6 months to 12 years of age 4
  • Food delays absorption rate (Tmax increases from 1.93 to 2.79 hours) but does not affect total drug exposure 4
  • This allows flexible dosing around meal times without compromising efficacy 4

Age Restrictions

  • Limited data exists for infants younger than 5 months, and alternative agents may be preferred in this age group 2
  • Approved for use starting at 2 months of age per FDA labeling 1

Important Caveats

Maximum Dose Limits

  • Pediatric doses should never exceed adult doses regardless of weight 1
  • Adult maximum: 400 mg per dose for most indications 1

Renal Impairment

  • For severe renal impairment (creatinine clearance <30 mL/min), extend dosing interval to every 24 hours 1
  • For patients on hemodialysis, dose 3 times per week after dialysis 1

Duration Considerations

  • 5-day courses have demonstrated equivalent efficacy to 10-day regimens for acute otitis media and pharyngitis 5, 6
  • This shorter duration minimizes antibiotic exposure and resistance selection while maintaining clinical effectiveness 5

References

Guideline

Cefpodoxime Use in Pediatric Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cefpodoxime pharmacokinetics in children: effect of food.

The Pediatric infectious disease journal, 1998

Research

Cefpodoxime: pharmacokinetics and therapeutic uses.

Indian journal of pediatrics, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.